Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04549766

Predictive Value of PRECISE DAPT Score in STEMI Patients After Primary PCI

ST-segment Elevation Myocardial Infarction (STEMI) Clinical Trial

Official title:
The Predictive Value of PRECISE DAPT Score in Patients With ST Segment Elevation Myocardial Infarction (STEMI) After Primary Percutaneous Coronary Intervention (PPCI)

Clinical Trial Summary

To investigate the predictive value of PRECISE DAPT score in relation to coronary slow flow & other short term major adverse cardiovascular events (MACE) post PPCI .

Clinical Trial Description

Coronary artery disease (CAD) is the leading cause of death around the world and more than 4 million people die every year due to CAD in Europe.[1] The incidence of ST elevation myocardial infarction (STEMI) appears to be declining; however, it is still an important issue in cardiovascular medicine.[2] Initial risk assessment is important for STEMI to estimate adverse cardiovascular outcomes. Previous studies demonstrated that increased age, advanced Killip class, heart rate, arterial hypotension, increased serum creatinine, white blood cell counts, and hemoglobin levels were predictors of in-hospital and early mortality in patients with STEMI treated with primary percutaneous coronary intervention (PPCI).[3,4 ]Therefore, risk scores including the aforementioned parameters were developed to estimate mortality in patients with STEMI.

No-reflow is still a challenging major issue in the management of the patients with STEMI undergoing primary PCI. It is defined as inadequate myocardial perfusionthrough a given segment of the coronary circulation without angiographic evidence of mechanical vessel obstructionas [5] Angiographic no-reflow defined as less than Thrombolysis In Myocardial Infarction (TIMI) 3 flow [6] and angiographic success was defined as TIMI Grade 3 Flow .

PRECISE-DAPT score includes age, creatinine clearance, white blood cell counts, hemoglobin levels, and prior spontaneous bleeding [7]. All these factors have a close relationship with coronary artery disease (CAD) and complications [8-10]. Therefore, in this study, we aimed to evaluate the association of admission PRECISE-DAPT score with the development of slow flow & bleeding & othershort term cardiovascular complications that develop in patients with STEMI treated with primary PCI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04549766
Study type Observational
Source Assiut University
Contact Madonna Atef, Resident
Phone 01012767967
Email donna.atef555@gmail.com
Status Not yet recruiting
Phase
Start date September 2020
Completion date October 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04962178 - Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset N/A
Not yet recruiting NCT05511831 - The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI Phase 4
Active, not recruiting NCT05649696 - Prolonged Clinical Follow-up of OPTIMA-5 Phase 4
Completed NCT01144819 - Platelet Inhibition in the Acute Phase of STEMI N/A
Recruiting NCT03539133 - Systemic Organ Communication in STEMI
Not yet recruiting NCT05506449 - The RECOVER IV Trial N/A
Completed NCT01642667 - Pharmacoinvasive Therapy With Prourokinase Phase 2/Phase 3
Completed NCT04131816 - HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program N/A
Recruiting NCT03768453 - EARLY-MYO-CMR Registry
Completed NCT04942977 - Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy N/A
Recruiting NCT04912518 - Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction N/A
Completed NCT04996901 - The Chinese STEMI PPCI Registry (CSPR)
Completed NCT02197117 - Effect of Remote Ischemic Conditioning in Heart Attack Patients N/A
Completed NCT02733341 - The Effect of IV Cangrelor and Oral Ticagrelor Study Phase 4
Not yet recruiting NCT04110691 - Impact of Stent Length and Diameter on Patients Undergoing Primary PCI
Recruiting NCT05709626 - PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction Phase 4
Active, not recruiting NCT04828681 - Angio-IMR and Cardiac MR-derived MVO in STEMI Patients
Recruiting NCT04300582 - Fast Radial Pharmaco-invasive Strategy In ST Elevation Myocardial Infarction Trial N/A
Recruiting NCT05319366 - Atherosclerotic Lesion Proteomics by Harvesting Angioplasty Balloons (ALPHA).
Not yet recruiting NCT04575012 - Compare Early With Deferred Invasive Strategy for STEMI Presenting 24-48 Hours From Symptom Onset N/A